Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF Mouthwash for Mucositis in Head and Neck Cancer
NCT00293462Phase 3Completed
- Start
- Jun 2005
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sargramostim in oral mucositis (OM) (3 arms). Primary endpoints: Incidence of Grade 1 or 2 Oral Mucositis and Mean Number of Days for Mucositis to Heal. Started Jun 2005; status: completed.
02
Drugs
sargramostim
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00293462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293462.